Results 91 to 92 of about 918 (92)

[Neuroendocrine tumor therapy (NETTER-1) trial: 177Lu-DOTA-TATE for neuroendocrine tumors].

Der Radiologe, 2018
openaire   +1 more source

1168P Overall survival (OS) and progression-free survival (PFS) in patients with advanced, non-resectable, progressive rectal NET treated with 90Y DOTA-TATE, 177Lu DOTA-TATE and mix of both as systemic radioligand therapy: Real-world data

Annals of Oncology
J.B. Cwikla, A.D. Kolasińska-Ćwikła, A. Sankowski, J. Pałucki, K. Roszkowska-Purska, E. Chrapowicki, T. Ostrowski   +6 more
openaire   +1 more source